| Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273) |
|---|
| 01/09/2013 | CN102863376A N-substituted methyl-3,5-disubstituted benzylidene base-4-piperidone and preparation method and application thereof |
| 01/09/2013 | CN102863375A Method for synthesizing and preparing 2-vinyl pyridine |
| 01/09/2013 | CN102863362A Aryl compounds as ppar ligands and their use |
| 01/09/2013 | CN102863305A Preparation method of amide from nitrile |
| 01/09/2013 | CN102219731B Production method of pyridine base |
| 01/09/2013 | CN102153508B 3,5-(E)-dibenzylidene-N-cyclopropyl piperidine-4-ketone and application of the 3,5-(E)-dibenzylidene-N-cyclopropyl piperidine-4-ketone in preparing antitumour drugs |
| 01/09/2013 | CN102093286B Acrylic acid endothelin receptor antagonist as well as preparation method and application thereof |
| 01/08/2013 | US8350047 Methods of preparing secondary carbinamine compounds with boronic acids |
| 01/08/2013 | US8350046 Method for manufacturing aryl carboxamides |
| 01/08/2013 | US8350043 Azinone and diazinone V3 inhibitors for depression and stress disorders |
| 01/08/2013 | US8350026 VEGF-2 receptor and protein tyrosine kinase inhibitors and pharmaceutical use thereof |
| 01/08/2013 | US8349876 Pyridine non-classical cannabinoid compounds and related methods of use |
| 01/08/2013 | US8349872 Tripyridyl carboxamide orexin receptor antagonists |
| 01/08/2013 | CA2597393C Improved process for the preparation of 3,5-diethyl-1,2-dihydro-1-phenyl-2-propylpyridine |
| 01/08/2013 | CA2565013C Method for producing pentacyclic taxans |
| 01/08/2013 | CA2517486C 6-alkyl or alkenyl-4-aminopicolinates and their use as herbicides |
| 01/08/2013 | CA2478731C Carbamates as hiv protease inhibitors |
| 01/08/2013 | CA2447671C Trisubstituted-n-[(1s)-1,2,3,4-tetrahydro-1-naphthalenyl] benzamides which inhibit p2x3 and p2x2/3 containing receptors |
| 01/03/2013 | WO2013003505A1 Amido-pyridyl ether compounds and compositions and their use against parasites |
| 01/03/2013 | WO2013003445A1 Tetra-pyridine compounds and composition for protecting cells, tissues and organs against ischemia-reperfusion injury |
| 01/03/2013 | WO2013002638A1 Method and catalyst for the alkylation of aromatic compounds with alkanes |
| 01/03/2013 | WO2013002357A1 Hiv replication inhibitor |
| 01/03/2013 | WO2013002313A1 Weight control drug |
| 01/03/2013 | WO2013000395A1 Novel histone deacetylase inhibitor of benzamides and use thereof |
| 01/03/2013 | WO2013000273A1 Method for industrially preparing nitrogen substituted amino-5,6,7,8-tetrahydronaphthol |
| 01/03/2013 | WO2012116151A3 Vinyl -aryl - sulfones for use in peritoneal carcinomatosis |
| 01/03/2013 | US20130005981 PROCESS FOR PREPARATION OF t-BUTOXYCARBONYLAMINE COMPOUNDS |
| 01/03/2013 | US20130005980 Process for the preparation of sorafenib tosylate |
| 01/03/2013 | US20130005780 Controlled release pharmaceutical compositions of tapentadol |
| 01/03/2013 | US20130005778 Urethanes, ureas, amidines and related inhibitors of factor xa |
| 01/03/2013 | US20130005777 Sorafenib ethylsulfonate salt, process for preparation and use |
| 01/03/2013 | US20130005767 Therapeutic compounds |
| 01/03/2013 | US20130005765 Methods and Compositions for Controlling Ectoparasites |
| 01/03/2013 | US20130005744 Inhibitors of catechol o-methyl transferase and their use in the treatment of psychotic disorders |
| 01/03/2013 | US20130005735 Organic compounds |
| 01/03/2013 | US20130005689 Compounds for the treatment of addiction |
| 01/03/2013 | US20130005574 3-alkoxy, thioalkyl and amino-4-amino-6-(substituted)picolinates and their use as herbicides |
| 01/03/2013 | US20130002526 Novel organic compound and organic light-emitting device |
| 01/03/2013 | CA2840396A1 Amido-pyridyl ether compounds and compositions and their use against parasites |
| 01/03/2013 | CA2839366A1 Method for industrially preparing nitrogen substituted amino-5,6,7,8-tetrahydronaphthol |
| 01/03/2013 | CA2836998A1 Method and catalyst for the alkylation of aromatic compounds with alkanes |
| 01/02/2013 | EP2540727A1 Sulfamoylating reagent |
| 01/02/2013 | EP2540708A1 Metal complex, and adsorbent, occlusion material and separator material made from same |
| 01/02/2013 | EP2540707A1 Substituted pyridyl compound and organic electroluminescent element |
| 01/02/2013 | EP2540691A1 Method and catalyst for the alkylation of aromatic compounds with light alkanes |
| 01/02/2013 | EP2539323A1 Compounds as bradykinin b1 antagonists |
| 01/02/2013 | CN102858745A Acylamino-substituted cyclic carboxylic acid derivatives and their use as pharmaceuticals |
| 01/02/2013 | CN102858340A Prophylactic or therapeutic agent for diseases associated with pains in urinary organs |
| 01/02/2013 | CN102850321A Aroxylpyrimidine formamide or aroxylpyridine formamide compound and its preparation method, pharmaceutical composition, and application |
| 01/02/2013 | CN102850267A Novel sorafenib tosylate polycrystalline form and preparation method thereof |
| 01/02/2013 | CN102850266A Preparation method of Roflumilast |
| 01/02/2013 | CN102850265A Flupirtine conjugate and preparation method and use thereof |
| 01/02/2013 | CN102850264A Flupirtine A crystal form and its preparation method |
| 01/02/2013 | CN102850236A Novel benzamide histone deacetylase inhibitor and application thereof |
| 01/02/2013 | CN102850156A Method for synthesizing o-amino diaryl ether and o-amino diaryl sulfur ether |
| 01/02/2013 | CN102845429A Preparation method of picloram choline water aqua and picloram choline original drug |
| 01/02/2013 | CN102001971B N-(4-guanidyl butyl) syringoylagmatine derivatives and pharmaceutical applications thereof |
| 01/02/2013 | CN101972672B S-acylation L-cysteine and application of salt thereof as catalyst for asymmetrical organic synthesis reaction |
| 01/02/2013 | CN101925634B Diamine compound, liquid crystal aligning agent, and liquid crystal display device using the same |
| 01/02/2013 | CN101906068B Preparation method of 2-pyridine carboxaldehyde |
| 01/02/2013 | CN101663275B Pyridine compounds for liquid-crystalline mixtures |
| 01/02/2013 | CN101595084B Biaryl compositions and methods for modulating a kinase cascade |
| 01/02/2013 | CN101479243B Glycine transporter-1 inhibitors |
| 01/02/2013 | CN101400654B 1,4-disubstituted 3-cyano-pyridone derivatives and their use as positive allosteric modulators of MGLUR2-receptors |
| 01/02/2013 | CN101365681B Iminopropene compound and use thereof |
| 01/01/2013 | US8344152 Process for producing pyridylethylthio compound, modified ion exchanger and process for producing the same, and process for producing bisphenol compound |
| 01/01/2013 | US8344146 Inhibitor of DD-peptidase and its use as antibiotic or anticancer drug |
| 01/01/2013 | US8344002 Compound having β-secretase inhibitory activity |
| 01/01/2013 | US8343988 Inhibitors of histone deacetylase |
| 01/01/2013 | US8343966 Organic compounds |
| 01/01/2013 | US8343963 Sulfamoyl-phenyl-ureido compounds and their use as medicament |
| 01/01/2013 | US8343952 Prolyl hydroxylase inhibitors and methods of use |
| 01/01/2013 | US8343893 Substituted enaminocarbonyl compounds |
| 01/01/2013 | US8343450 Functionalized carbon nanotubes, recovery of radionuclides and separation of actinides and lanthanides |
| 12/27/2012 | WO2012177956A1 Ppar-sparing compounds for use in the treatment of diabetes and other metabolic diseases |
| 12/27/2012 | WO2012177896A1 Trpm8 antagonists and their use in treatments |
| 12/27/2012 | WO2012177893A2 Trpm8 antagonists and their use in treatments |
| 12/27/2012 | WO2012175962A1 COMPOUNDS FOR USE IN STABILISING p53 MUTANTS |
| 12/27/2012 | WO2012175715A1 Piperazine derivatives, methods for preparing same, and uses thereof in the treatment of insulin resistance |
| 12/27/2012 | WO2012175707A1 Piperazine derivatives, methods for preparing same, and uses thereof in the treatment of insulin resistance |
| 12/27/2012 | WO2012143771A8 Improved catalytic process for production of pyridine carboxylic acid amides |
| 12/27/2012 | WO2012122383A3 Pi3 kinase inhibitors and uses thereof |
| 12/27/2012 | WO2011108963A8 Urethanes, ureas, amidines and related inhibitors of factor xa |
| 12/27/2012 | US20120330023 Alkyl Pyridinium Dicyanamides and Method For The Production Thereof |
| 12/27/2012 | US20120329711 Glp-1 receptor agonist compounds with a modified n-terminus |
| 12/27/2012 | US20120328514 N-alkoxyamide conjugates as imaging agents |
| 12/27/2012 | CA2839703A1 Trpm8 antagonists and their use in treatments |
| 12/27/2012 | CA2839699A1 Trpm8 antagonists and their use in treatments |
| 12/26/2012 | EP2537830A1 Compounds and compositions as protein kinase inhibitors |
| 12/26/2012 | EP2537829A1 Aminobenzoylsulfamides and their preparation |
| 12/26/2012 | EP2537826A1 Fluorination of aromatic ring systems |
| 12/26/2012 | EP2536691A1 Bifunctional chelating agents |
| 12/26/2012 | EP2536690A1 Multifunctional radical quenchers and their use |
| 12/26/2012 | EP2536689A1 Aryl carboxamide derivatives as sodium channel inhibitors for treatment of pain |
| 12/26/2012 | EP2536286A1 Inhibitors and methods of inhibiting bacterial and viral pathogens |
| 12/26/2012 | CN102844386A Use of physiological cooling active ingredients, and agents containing such active ingredients |
| 12/26/2012 | CN102844302A Nitrogen-containing heterocyclic compound and method for producing same |
| 12/26/2012 | CN102839213A Mass labels |
| 12/26/2012 | CN102838546A Pyrazole derivatives as modulators of 5-ht2a serotonin receptor useful for treatment of disorders related thereto |
| 12/26/2012 | CN102838537A Preparation method of lansoprazole intermediate |